| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/03/2008 | WO2008079657A1 Antitumorigenic drug combination |
| 07/03/2008 | WO2008079629A2 Formulations with improved bioavailability |
| 07/03/2008 | WO2008079610A2 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 07/03/2008 | WO2008079570A1 Spirocyclic azaadamantane derivatives and methods of use |
| 07/03/2008 | WO2008079460A2 Tyrosine kinase inhibitors for prevention or treatment of infection |
| 07/03/2008 | WO2008079427A1 1,2,3,4-tetrahydro-quinoline derivatives as cetp inhibitors |
| 07/03/2008 | WO2008079406A2 Gene expression markers for inflammatory bowel disease |
| 07/03/2008 | WO2008079398A1 Methods for treating obesity with a combination comprising a mtp inhibitor and a cholesterol absorption inhibitor |
| 07/03/2008 | WO2008079387A1 Catechol protected levodopa diester prodrugs, compositions, and methods of use |
| 07/03/2008 | WO2008079383A1 Prostacyclin derivatives |
| 07/03/2008 | WO2008079382A1 Sphingosine-1 -phosphate receptor agonist and antagonist compounds |
| 07/03/2008 | WO2008079371A1 Modulators of c3a receptor and methods of use thereof |
| 07/03/2008 | WO2008079363A2 Substituted tetracycline compounds for treatment of inflammatory skin disorders |
| 07/03/2008 | WO2008079355A2 Method and system for enhancing self-treatment of onychomycosis |
| 07/03/2008 | WO2008079346A1 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | WO2008079328A2 Omega-5-fatty acids useful in lipoxygenase 5 inhibition and in the treatment of cancer |
| 07/03/2008 | WO2008079316A1 Tetrahydroquinolinones, tetrahydronaphthyridones and derivatives thereof |
| 07/03/2008 | WO2008079312A2 Compositions for treatment of nasal congestion |
| 07/03/2008 | WO2008079293A1 Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity |
| 07/03/2008 | WO2008079292A1 Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer |
| 07/03/2008 | WO2008079287A1 Method of improving cardiovascular health |
| 07/03/2008 | WO2008079279A1 Heterocyclic compounds with cxcr3 antagonist activity |
| 07/03/2008 | WO2008079277A1 Certain pyrazoline derivatives with kinase inhibitory activity |
| 07/03/2008 | WO2008079266A2 Synthesis of pyrrolidine compounds |
| 07/03/2008 | WO2008079257A2 Methods for treating nasal congestion in pediatric patients |
| 07/03/2008 | WO2008079256A2 Methods for treating nasal congestion in hypertensive or diabetic patients |
| 07/03/2008 | WO2008079255A1 Synthesis of unsaturated piperidines from piperidones with a silyl reagent |
| 07/03/2008 | WO2008079245A2 Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof |
| 07/03/2008 | WO2008079240A1 Use of liposome-entrapped agents for treating tumors |
| 07/03/2008 | WO2008079159A2 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 07/03/2008 | WO2008079139A1 Abca1 elevating compounds |
| 07/03/2008 | WO2008079105A1 Methods to synthesize indoles as precursors for pharmaceuticals |
| 07/03/2008 | WO2008079073A1 Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 07/03/2008 | WO2008079030A1 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| 07/03/2008 | WO2008078842A1 Ciclesonide containing sterile aqueous suspension |
| 07/03/2008 | WO2008078837A1 2-substituted-6-heterocyclic pyrimidone derivatives as tau protein kinase 1 inhbitors |
| 07/03/2008 | WO2008078826A1 Therapeutic agent for diabetic neuropathy |
| 07/03/2008 | WO2008078797A1 Sodium absorption inhibitor, potassium absorption inhibitor, phosphorus absorption inhibitor and preventive agent, therapeutic agent and food containing the same |
| 07/03/2008 | WO2008078795A1 Metal salt of crosslinked cellulose derivative |
| 07/03/2008 | WO2008078785A1 Klf5 suppressor and method for selecting active ingredient of the medicament |
| 07/03/2008 | WO2008078762A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure |
| 07/03/2008 | WO2008078730A1 Preparation for transnasal application |
| 07/03/2008 | WO2008078729A1 Method for improving dissolution property |
| 07/03/2008 | WO2008078728A1 Ascorbic acid-containing pharmaceutical composition |
| 07/03/2008 | WO2008078727A1 Pharmaceutical composition having improved dissolution property |
| 07/03/2008 | WO2008078726A1 Solid preparation |
| 07/03/2008 | WO2008078725A1 Thiazepine derivative |
| 07/03/2008 | WO2008078723A1 Antibacterial agent and bactericidal agent |
| 07/03/2008 | WO2008078674A1 Glucokinase-activating substance |
| 07/03/2008 | WO2008078453A1 Platelet production promoting factor and use thereof |
| 07/03/2008 | WO2008078423A1 Composition containing plant sterol and phosphatidylcholine and process for producing the same |
| 07/03/2008 | WO2008078420A1 Anti-arteriosclerotic agent |
| 07/03/2008 | WO2008078411A1 Pharmaceutical agent for prevention and/or treatment of inflammatory myopathy |
| 07/03/2008 | WO2008078387A1 Fermented milk for improving and/or treating skin and method for producing the same |
| 07/03/2008 | WO2008078362A1 Antitumor agent and food containing the same |
| 07/03/2008 | WO2008078353A1 A novel use of antidepressant compounds and related compositions |
| 07/03/2008 | WO2008078249A1 Anti-inflammatory agents |
| 07/03/2008 | WO2008078176A1 Methods, compounds, and compositions for treating metabolic disorders and diabetes |
| 07/03/2008 | WO2008078100A2 Tricyclic amine derivatives as protein tyrosine kinase inhibitors |
| 07/03/2008 | WO2008078099A1 Lxr- antagonists for the prevention, reduction or inhibition of scarring |
| 07/03/2008 | WO2008078096A2 Medicaments and methods for promoting wound contraction |
| 07/03/2008 | WO2008078095A1 Treatment of macular degeneration |
| 07/03/2008 | WO2008078091A1 Bicyclic heterocyclic compounds as fgfr inhibitors |
| 07/03/2008 | WO2008078086A1 Combination of an mek inhibitor and the src kinase inhibitor azd0530 for use in the treatment of cancer |
| 07/03/2008 | WO2008078076A1 Morpholino compound microemulsion |
| 07/03/2008 | WO2008078074A1 Promotion of wound contraction with a compound that promotes oestrogenic activity |
| 07/03/2008 | WO2008078073A1 Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing |
| 07/03/2008 | WO2008078071A1 Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing |
| 07/03/2008 | WO2008078069A1 Indolizineacetic acids and their therapeutic use as ligands of the crth2 receptor |
| 07/03/2008 | WO2008078057A1 Protein complex and uses |
| 07/03/2008 | WO2008077978A1 Therapeutic agent for treatment of bipolar affective disorder in mammals |
| 07/03/2008 | WO2008077939A2 Duloxetine composition |
| 07/03/2008 | WO2008077916A1 Pharmaceutical composition using aliskiren and avosentan |
| 07/03/2008 | WO2008077885A2 2- [(phenylamino) -pyrimidin-4ylamin0] -cyclopentane carboxamide derivatives and related compounds as inhibitors of kinases of the cell cycle for the treatment of cancer |
| 07/03/2008 | WO2008077871A1 Salts of tegaserod |
| 07/03/2008 | WO2008077811A1 Spiro-piperidine derivatives |
| 07/03/2008 | WO2008077810A2 Spiro-piperidine derivatives |
| 07/03/2008 | WO2008077772A2 Combination of a retinoid and a platinum anticancer agent |
| 07/03/2008 | WO2008077651A1 Pyrido(3,2-d)pyrimidines useful for treating viral infections |
| 07/03/2008 | WO2008077650A1 Pyrido(3,2-d)pyrimidines useful for treating viral infections |
| 07/03/2008 | WO2008077649A1 Pyrido(3,2-d)pyrimidines useful for treating viral infectons |
| 07/03/2008 | WO2008077647A2 Alpha- amino alcohols as non-steroidal progesterone receptor modulators |
| 07/03/2008 | WO2008077646A1 Non-steroidal progesterone receptor modulators |
| 07/03/2008 | WO2008077641A1 Nanoemulsion |
| 07/03/2008 | WO2008077639A1 Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors |
| 07/03/2008 | WO2008077625A1 Heterocyclyl-substituted-ehylamino-phenyl derivatives, their preparation and use as medicaments |
| 07/03/2008 | WO2008077618A1 Use of xanthohumol and/or isoxanthohumol as an agent for preventing and/or combating liver diseases |
| 07/03/2008 | WO2008077597A1 1-aminomethyl- l- phenyl- cyclohexane derivatives as ddp-iv inhibitors |
| 07/03/2008 | WO2008077591A2 Pharmaceutical formulation comprising neurokinin antagonist |
| 07/03/2008 | WO2008077557A1 8-ethinylxanthine derivatives as selective a2a receptor antagonists |
| 07/03/2008 | WO2008077556A1 Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives |
| 07/03/2008 | WO2008077554A1 Cycloalkylamine substituted isoquinoline derivatives |
| 07/03/2008 | WO2008077553A1 Cycloalkylamine substituted isoquinolone and isoquinolinone derivatives |
| 07/03/2008 | WO2008077552A1 Substituted isoquinoline and isoquinolinone derivatives |
| 07/03/2008 | WO2008077551A1 Cycloalkylamine substituted isoquinolone derivatives |
| 07/03/2008 | WO2008077550A1 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase |
| 07/03/2008 | WO2008077548A1 Pyrimidyl derivatives as protein kinase inhibitors |
| 07/03/2008 | WO2008077542A1 3-hydroxychlormadinone acetate for the topical treatment of androgen-dependent skin diseases |
| 07/03/2008 | WO2008077541A1 Active ingredient combination of a retinoid and a hormone combination with contraceptive action as medicament for treatment of skin diseases |
| 07/03/2008 | WO2008077453A1 5-fluorouracil derivatives and their use for the treatment of cancer |